CN115820921A - Primer probe combination for detecting three kinds of lung invasive fungi and digital PCR kit thereof - Google Patents
Primer probe combination for detecting three kinds of lung invasive fungi and digital PCR kit thereof Download PDFInfo
- Publication number
- CN115820921A CN115820921A CN202211632077.1A CN202211632077A CN115820921A CN 115820921 A CN115820921 A CN 115820921A CN 202211632077 A CN202211632077 A CN 202211632077A CN 115820921 A CN115820921 A CN 115820921A
- Authority
- CN
- China
- Prior art keywords
- seq
- atto
- probe
- group
- detecting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000523 sample Substances 0.000 title claims abstract description 95
- 238000007847 digital PCR Methods 0.000 title claims abstract description 15
- 210000004072 lung Anatomy 0.000 title claims abstract description 13
- 241000233866 Fungi Species 0.000 title claims abstract description 11
- 238000001514 detection method Methods 0.000 claims abstract description 58
- 201000007336 Cryptococcosis Diseases 0.000 claims abstract description 22
- 241000221204 Cryptococcus neoformans Species 0.000 claims abstract description 22
- 241001225321 Aspergillus fumigatus Species 0.000 claims abstract description 20
- 229940091771 aspergillus fumigatus Drugs 0.000 claims abstract description 19
- 241000607734 Yersinia <bacteria> Species 0.000 claims abstract description 15
- 244000052616 bacterial pathogen Species 0.000 claims abstract description 9
- 238000000034 method Methods 0.000 claims description 17
- 238000010791 quenching Methods 0.000 claims description 10
- 230000000171 quenching effect Effects 0.000 claims description 10
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 9
- 241000228212 Aspergillus Species 0.000 claims description 8
- 208000015181 infectious disease Diseases 0.000 claims description 8
- 125000006853 reporter group Chemical group 0.000 claims description 8
- 208000019693 Lung disease Diseases 0.000 claims description 6
- 239000002773 nucleotide Substances 0.000 claims description 6
- 125000003729 nucleotide group Chemical group 0.000 claims description 6
- 241000233870 Pneumocystis Species 0.000 claims description 5
- 201000000317 pneumocystosis Diseases 0.000 claims description 5
- 201000010099 disease Diseases 0.000 claims description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 4
- UDGUGZTYGWUUSG-UHFFFAOYSA-N 4-[4-[[2,5-dimethoxy-4-[(4-nitrophenyl)diazenyl]phenyl]diazenyl]-n-methylanilino]butanoic acid Chemical compound COC=1C=C(N=NC=2C=CC(=CC=2)N(C)CCCC(O)=O)C(OC)=CC=1N=NC1=CC=C([N+]([O-])=O)C=C1 UDGUGZTYGWUUSG-UHFFFAOYSA-N 0.000 claims description 2
- VLPJFMZVPMTRLU-UHFFFAOYSA-N 4-[[2-[3-(ethylamino)-6-ethylimino-4,5-disulfoxanthen-9-yl]benzoyl]-methylamino]butanoic acid Chemical compound C=12C=CC(=NCC)C(S(O)(=O)=O)=C2OC2=C(S(O)(=O)=O)C(NCC)=CC=C2C=1C1=CC=CC=C1C(=O)N(C)CCCC(O)=O VLPJFMZVPMTRLU-UHFFFAOYSA-N 0.000 claims description 2
- WNDDWSAHNYBXKY-UHFFFAOYSA-N ATTO 425-2 Chemical compound CC1CC(C)(C)N(CCCC(O)=O)C2=C1C=C1C=C(C(=O)OCC)C(=O)OC1=C2 WNDDWSAHNYBXKY-UHFFFAOYSA-N 0.000 claims description 2
- YIXZUOWWYKISPQ-UHFFFAOYSA-N ATTO 565 para-isomer Chemical compound [O-]Cl(=O)(=O)=O.C=12C=C3CCC[N+](CC)=C3C=C2OC=2C=C3N(CC)CCCC3=CC=2C=1C1=CC(C(O)=O)=CC=C1C(O)=O YIXZUOWWYKISPQ-UHFFFAOYSA-N 0.000 claims description 2
- PWZJEXGKUHVUFP-UHFFFAOYSA-N ATTO 590 meta-isomer Chemical compound [O-]Cl(=O)(=O)=O.C1=2C=C3C(C)=CC(C)(C)N(CC)C3=CC=2OC2=CC3=[N+](CC)C(C)(C)C=C(C)C3=CC2=C1C1=CC=C(C(O)=O)C=C1C(O)=O PWZJEXGKUHVUFP-UHFFFAOYSA-N 0.000 claims description 2
- KIDFITUZQAFBTK-UHFFFAOYSA-N ATTO 635-2 Chemical compound [O-]Cl(=O)(=O)=O.C1=C2C(C)=CC(C)(C)[N+](CCCC(O)=O)=C2C=C2C1=CC1=CC=C(N(C)C)C=C1C2(C)C KIDFITUZQAFBTK-UHFFFAOYSA-N 0.000 claims description 2
- 238000000137 annealing Methods 0.000 claims description 2
- 230000004087 circulation Effects 0.000 claims description 2
- 238000004925 denaturation Methods 0.000 claims description 2
- 230000036425 denaturation Effects 0.000 claims description 2
- 238000003745 diagnosis Methods 0.000 claims description 2
- 238000012257 pre-denaturation Methods 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 claims description 2
- ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims 1
- 108020005196 Mitochondrial DNA Proteins 0.000 abstract description 11
- 230000035945 sensitivity Effects 0.000 abstract description 4
- 108020004414 DNA Proteins 0.000 description 10
- 241000894006 Bacteria Species 0.000 description 9
- 230000003321 amplification Effects 0.000 description 8
- 238000003199 nucleic acid amplification method Methods 0.000 description 8
- 241000894007 species Species 0.000 description 6
- 201000002909 Aspergillosis Diseases 0.000 description 5
- 208000036641 Aspergillus infections Diseases 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 241001337994 Cryptococcus <scale insect> Species 0.000 description 4
- 241000725303 Human immunodeficiency virus Species 0.000 description 4
- 206010035664 Pneumonia Diseases 0.000 description 4
- 206010036790 Productive cough Diseases 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 208000024794 sputum Diseases 0.000 description 4
- 210000003802 sputum Anatomy 0.000 description 4
- 238000002054 transplantation Methods 0.000 description 4
- 229910021642 ultra pure water Inorganic materials 0.000 description 4
- 239000012498 ultrapure water Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 238000011529 RT qPCR Methods 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 210000003470 mitochondria Anatomy 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 108020000946 Bacterial DNA Proteins 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 108020004566 Transfer RNA Proteins 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000003527 eukaryotic cell Anatomy 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 210000003463 organelle Anatomy 0.000 description 2
- 230000002685 pulmonary effect Effects 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 108020004463 18S ribosomal RNA Proteins 0.000 description 1
- 108020005096 28S Ribosomal RNA Proteins 0.000 description 1
- 241000228197 Aspergillus flavus Species 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 241000123346 Chrysosporium Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000223935 Cryptosporidium Species 0.000 description 1
- 208000031886 HIV Infections Diseases 0.000 description 1
- 208000037357 HIV infectious disease Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 208000029462 Immunodeficiency disease Diseases 0.000 description 1
- 206010062016 Immunosuppression Diseases 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- 241000208125 Nicotiana Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 208000037581 Persistent Infection Diseases 0.000 description 1
- 206010035742 Pneumonitis Diseases 0.000 description 1
- 208000004756 Respiratory Insufficiency Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 241000235013 Yarrowia Species 0.000 description 1
- 230000004103 aerobic respiration Effects 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 description 1
- 230000007813 immunodeficiency Effects 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- 201000004193 respiratory failure Diseases 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention relates to the technical field of biology, in particular to a primer probe combination for detecting three lung invasive fungi and a digital PCR detection kit thereof. The primer probe combination designed based on the specific conserved region of the mitochondrial gene of the pathogenic bacteria can realize the rapid detection of three pathogenic bacteria of aspergillus fumigatus, cryptococcus neoformans and yersinia sporogenes, and has good accuracy and specificity and high sensitivity.
Description
Technical Field
The invention relates to the technical field of biology, in particular to a primer probe combination for detecting three lung invasive fungi and a digital PCR kit thereof.
Background
Aspergillus is the most infectious mould species, and 3176 of the mould species and 1378 of the mould species have been found, wherein more than 250 of the broad-spectrum nature 40 are pathogenic bacteria. Aspergillus can parasitize the skin and upper respiratory tract of normal people, and is a conditional pathogen. The normal people have certain resistance to aspergillus and do not cause diseases. Aspergillosis is mostly secondary, when the resistance of an organism is reduced, pathogenic bacteria can pass through a skin mucous membrane injury part or be inhaled into a respiratory tract, and then enter blood circulation to other tissues or organs to cause diseases. Patients with immunosuppression, malignancy, organ transplantation (common in lung transplantation) are the major patient population with aspergillus infection. The main infection sites of aspergillus are the lungs, which are divided into three main groups: allergic bronchial infection, chronic infection, and invasive infection. The aspergillus mainly infecting the lung includes aspergillus fumigatus, aspergillus flavus, aspergillus niger and the like. The tobacco aspergillosis accounts for more than 90% of all aspergillosis.
Cryptococcosis is a pulmonary or disseminated infectious disease caused by cryptococci, mainly resulting in pneumonia and meningitis, and also in infections of the skin, bones or internal organs. There are more than 70 cryptococci found so far, of which 7 infect humans: two subspecies of cryptococcus neoformans and 5 subspecies of cryptococcus gatherens, with cryptococcosis neoformans accounting for about 90% of all cryptococcosis. The cryptococcosis population is mainly immunodeficiency patients, such as HIV infection, malignant tumor, stem cell or organ transplantation, autoimmune disease and nervous system complications.
Yersinia pneumonitis pneumonia is pneumonia caused by pneumocystis, and there are two main groups of infections: HIV virus infected and non-HIV virus infected, HIV virus infected persons are progressing slowly; non-HIV virus infected persons are mainly: the patient with malignant blood disease, organ transplantation receptor and cancer chemotherapy patient are characterized in that: rapid progress, high incidence of respiratory failure and high mortality.
Mitochondria, also known as the energy supply station of eukaryotic cells, are an important organelle in eukaryotic cells because aerobic respiration occurs within mitochondria. As a semi-autonomous organelle, mitochondria possess a certain number of genetic systems, called mitochondrial genes, independent of the nucleus.
Because fungi are difficult to culture and grow slowly, the main method for detecting aspergillus infection at present is GM detection, and the defect of the GM detection is that the GM detection can cause false positive results under the influence of certain foods or medicines; the cryptococcus is clinically diagnosed by combining clinical manifestations and microscopic examination results, and is confirmed by fungus culture or tissue staining; the pneumocystis yezoensis is clinically diagnosed by combining clinical manifestations and microscopic examination results. There are also several patents for detecting aspergillus, cryptococcus and yersinia by utilizing qPCR technology, but the detection targets of the patents are genomic DNAs (18S RNA, ITS region or 28S RNA) of one species of aspergillus fumigatus or three species of aspergillus fumigatus, cryptococcus or yersinia pneumocystis, and no report for joint detection of the above several species by utilizing a linear gene as the detection target exists at present.
Disclosure of Invention
In view of this, the invention provides a primer probe combination for detecting three kinds of lung invasive fungi and a digital PCR detection kit thereof. The primer probe combination is combined with a digital PCR technology, can quickly realize the combined detection of aspergillus fumigatus, yersinia sporogenes and cryptococcus neoformans, and has good accuracy, high sensitivity and short detection time.
In order to achieve the above object, the present invention provides the following technical solutions:
a primer probe combination for detecting three lung invasive fungi comprising:
primers and probes for detecting aspergillus: 1-2 and 3, respectively;
and (3) primers and probes for detecting cryptococcus neoformans: primers of the nucleotide sequences shown in SEQ ID NO. 4-5 and probes of the nucleotide sequences shown in SEQ ID NO. 6; and/or
Primers and probes for detecting yersinia sporogenes: primers of the nucleotide sequences shown in SEQ ID NO. 7-8 and probes of the nucleotide sequences shown in SEQ ID NO. 9.
The primer probe combination is designed aiming at specific conserved regions of mitochondrial genes of aspergillus fumigatus, cryptococcus neoformans and yersinia sporogenes respectively, wherein nucleotide sequences of the conserved regions of the mitochondrial genes of aspergillus fumigatus, cryptococcus neoformans and yersinia sporogenes are shown as SEQ ID NO: 14-16 in sequence.
In the invention, the 5 'end of the probe is marked with a fluorescent group, and the 3' end of the probe is marked with a quenching group;
the fluorescent group is selected from FAM, ROX, VIC, CY5, ATTO-425, HEX, TAMRA, CY5.5, CY7, ATTO-488, ATTO-550, ATTO-565, ATTO-590, ATTO-635, ATTO-532, ATTO-549 and ATTO-633; the quenching group is selected from MGB or BHQ1, BHQ2 and BHQ3.
In some embodiments:
the 5 'end of the probe of the nucleotide sequence shown in SEQ ID NO. 3 is marked with a fluorescence reporter group FAM, and the 3' end is marked with a fluorescence quenching group MGB;
the 5 'end of the probe of the nucleotide sequence shown in SEQ ID NO. 6 is marked with a fluorescence reporter group ROX, and the 3' end is marked with a fluorescence quenching group MGB;
the 5 'end of the probe of the nucleotide sequence shown in SEQ ID NO. 9 is marked with a fluorescence reporter group CY5, and the 3' end is marked with a fluorescence quenching group MGB.
The invention also provides application of the primer probe combination in preparing a lung disease diagnosis kit. The pulmonary disease is a disease induced by infection with at least one pathogenic bacterium selected from the group consisting of Aspergillus fumigatus, cryptococcus neoformans and Chrysosporium yerianum.
The invention also provides a kit for diagnosing lung diseases, which comprises the primer probe combination.
In some embodiments, the kit of the present invention further comprises primers and probes designed for the conserved region of the internal reference IC (the sequence shown in SEQ ID No. 13): the primer sequence is shown as SEQ ID NO. 10-11; the probe sequence is shown in SEQ ID NO. 12. In some embodiments, the probe shown in SEQ ID NO. 12 is labeled with a fluorescent reporter group VIC at the 5 'end and a fluorescent quencher group BHQ1 at the 3' end.
The invention also provides a method for detecting lung pathogenic bacteria, which utilizes the primer probe combination or the kit to carry out digital PCR detection on a sample to be detected.
The program for digital PCR detection comprises: pre-denaturation at 98 ℃ for 5min; denaturation at 98 ℃ for 15 seconds, annealing at 60 ℃ for 30 seconds, and circulation for 40 times.
In the invention, the samples to be detected comprise human sputum samples, alveolar lavage fluid samples, blood samples and thoracoabdominal water samples. In some embodiments, the assays of the invention are assays for non-diagnostic purposes, such as assays on samples of an environment or on food samples, wherein the samples in the environment comprise water samples or swabs on the surface of an object.
The primer and the probe are designed aiming at the specific region of the mitochondrial genes of aspergillus fumigatus, yersinia sporogenes and cryptococcus neoformans, can quickly realize the joint detection of three pulmonary pathogenic bacteria of aspergillus fumigatus, yersinia sporogenes and cryptococcus neoformans, and has the characteristics of high sensitivity, good specificity and high repeatability.
Detailed Description
The invention provides a primer probe combination for detecting three kinds of lung invasive fungi and a digital PCR detection kit thereof. Those skilled in the art can modify the process parameters appropriately in view of the disclosure herein. It is expressly intended that all such similar substitutes and modifications which would be obvious to one skilled in the art are deemed to be included in the invention. While the methods and applications of this invention have been described in terms of preferred embodiments, it will be apparent to those of ordinary skill in the art that variations and modifications in the methods and applications described herein, as well as other suitable variations and combinations, may be made to implement and use the techniques of this invention without departing from the spirit and scope of the invention.
The test materials adopted by the invention are all common commercial products and can be purchased in the market.
The invention is further illustrated by the following examples:
example 1 System and method for primer probe screening and digital PCR detection of the invention
(first) screening of primer probes
6 pairs of primer probes are designed for each of the three bacteria, qPCR is carried out by taking plasmids of corresponding sequences of 10000 copies/mu l (stock solution), 1000 copies/mu l (10-fold dilution) and 100 copies/mu l (100-fold dilution) as templates, and the CT value and the maximum fluorescence value of 6 pairs of Aspergillus fumigatus detection are as follows:
TABLE 1
Because of the maximum fluorescence intensity of the amplification product, the difference between the gray values of the negative and positive droplets is determined in the droplet test digital PCR, in order to ensure the maximization of the difference between the gray values of the negative and positive droplets, a primer probe combination with the maximum fluorescence intensity of the amplification product larger is selected during the primer probe selection, and the third pair and the fourth pair can be selected by screening the primer probe combinations of 6 pairs of aspergillus fumigatus under the condition. Because 10 is about 3.3 times of 2, the detected CT value is increased by 3.3 for every 10 times of reduction of the template concentration, and the combination is considered to be the combination with the minimum influence by external conditions and can be selected for building a multiplex system. From these two factor analyses, primer probe combinations for 6 pairs of A.fumigatus we chose the third pair for the set-up of the system. Similarly, we selected the second and fifth pairs from 6 pairs of Cryptococcus neoformans and Yersinia sporogenes primer probes, and the specific sequences of the screened primer probes and their targets are shown in Table 2, and the sequences of the control primer probes of one pair are shown in Table 3.
TABLE 2
TABLE 3 control primer Probe sequences
(II) digital PCR detection system and method
1. Sample(s)
1.1 bacterial DNA sample: bacterial DNA samples: and (3) externally purchasing dead bacteria, and extracting DNA by a magnetic bead method.
1.2 human DNA samples: extracting genome DNA by a magnetic bead method by using sterile sputum/alveolar lavage fluid. 1.3 exogenous internal reference template: synthesized by biological companies, and dissolved and diluted for later use.
2 digital PCR amplification system
2.1 25 xBc primer probe mixture
TABLE 4
TABLE 5ddPCR reaction System
Reagent | Volume (μ L) | Final concentration |
Water (W) | 4.85 | |
5×ddPCR Mix | 3 | 1× |
IC-S | 1 | |
DNA | 5 | |
25 xBc primer probe mixture | 1.15 | |
Total up to | 15 |
2.2 amplification procedure
98℃5min【98℃15s,60℃30s】*40。
Example 2 specific detection
The following samples were tested with the primer probes of table 2 of example 1, and the results were as follows:
TABLE 6
The result shows that the primer probe combination has good specificity for detecting various common bacterial fungi, and has good stability for detecting three repetitions of aspergillus fumigatus, cryptococcus neoformans and cryptosporidium jejuni.
Example 3 detection of amplification efficiency
The amplification efficiency of the primer probes of tables 2 and 3 was examined, and the results are shown in Table 7.
TABLE 7
The results show that the Ct value increases by about 3 for each 10-fold decrease in primer probe concentration as a result of qPCR with the optimal primer probe concentrations screened in Table 4 and the concentrations of the above 3 artificially synthesized DNA templates, respectively. Since the power of 3.3 of 2 is equal to 10, the amplification efficiency of all primer probes in the system is close to 100%.
Example 4
Sputum samples positive for 4 cases of aspergillus fumigatus, 4 cases of cryptococcus neoformans and 4 cases of yersinia pneumocystis were tested using the primer probe system of the present invention and the 28sRNA primer probes (28 sRNA and a. Fum-MIT) shown in table 3. And extracting DNA of the sputum sample, and respectively adding 5 mu l of DNA into each system as a template.
The measurement values of Aspergillus fumigatus are shown in Table 7.
TABLE 7
Sample 1 (FAM) | Sample 2 (FAM) | Sample 3 (FAM) | Sample 4 (FAM) | |
28sRNA | 3.11copies/μl | 2.57copies/μl | 2.62copies/μl | 3.78copies/μl |
A.FUM-MIT | 1287copies/μl | 1001copies/μl | 1064copies/μl | 1479copies/μl |
In real sample detection, the detection concentration taking aspergillus fumigatus mitochondrial gene as a detection target is about 390 times that taking 28sRNA as the detection target, the detection rate of a positive sample is higher, and the detection concentration taking 28sRNA as the detection target is lower, so that a false negative result is easy to appear.
The values for Cryptococcus neoformans are shown in Table 8.
TABLE 8
Sample 1 (FAM) | Sample 2 (FAM) | Sample 3 (FAM) | Sample 4 (FAM) | |
28sRNA | 24.31copies/μl | 8.62copies/μl | 7.49copies/μl | 13.65copies/μl |
C.NEO-MIT | 233.62copies/μl | 87.52copies/μl | 76.23copies/μl | 138.23copies/μl |
In the real sample detection, the detection concentration taking the cryptococcus neoformans mitochondrial gene as the detection target is about 10 times that taking 28sRNA as the detection target, the detection rate of a positive sample is higher, and the detection concentration taking 28sRNA as the detection target is lower, so that a false negative result is easy to appear.
The values for Yersinia pneumonocystis are shown in Table 9.
TABLE 9
Sample 1 (FAM) | Sample 2 (FAM) | Sample 3 (FAM) | Sample 4 (FAM) | |
28sRNA | 24.31copies/μl | 8.62copies/μl | 7.49copies/μl | 13.65copies/μl |
IF-PNEU | 972.36copies/μl | 578.12copies/μl | 301.49copies/μl | 587.26copies/μl |
In real sample detection, the detection concentration of the yersinia sporogenes serving as a detection target is about 40 times that of 28sRNA serving as the detection target, the detection rate of a positive sample is higher, and the detection concentration of 28sRNA serving as the detection target is lower, so that a false negative result is easy to appear.
Example 5 blank detection Limit (LoB) values
20 parts of deionized water was extracted daily as a template, and the primer probe system (28 sRNA and mitochondrial gene) of the present invention was used on different amplification instruments for three consecutive days, once a day. Except that all detection values are 0, analyzing whether the detection result is in accordance with normal distribution by using a ss23.0 software S-W, and if the detection result is in accordance with the normal distribution, analyzing the LoB value by using a parameter method; if the distribution is not normal, analyzing the LoB value by a nonparametric method. The results were as follows:
watch 10
The maximum value of the results of 3 times of calculation using mitochondrial genes as detection targets is the LoB value, namely 0.09 copies/mu l of aspergillus fumigatus, 0.11 copies/mu l of cryptococcus neoformans and 0 copies/mu l of non-sporophyte yeri; the maximum of 3 calculations with 28sRNA as the detection target was the LoB value, i.e., 0.29copies/μ l for Aspergillus fumigatus, 0.19copies/μ l for Cryptococcus neoformans, and 0.21copies/μ l for yarrowia. The result shows that the specificity of the primer probe system taking the mitochondrial gene as the detection target is obviously higher than that of the primer probe system taking 28sRNA as the detection target.
Example 6 lowest detection Limit (LoD) value
1.1 minimum detection limit (LoD)
If LoB =0, adopting a probability unit scheme; if LoB ≠ 0, the classical scheme is employed. The largest LOD of 3 reagent batches was formulated as the final reported value.
1.1.1 probability Unit scheme
Using ultrapure water as a substrate, DNAs of different target bacteria at known concentrations were incorporated, respectively, to prepare positive specimens. Then, the samples were diluted with ultrapure water in a gradient manner.
The same set of instruments including a droplet generator, a PCR amplification instrument and a chip reader are used, and 3 batch reagents are used for respectively and repeatedly detecting different concentration gradients of each target bacterium sample for 30 times.
And respectively calculating the positive detection rate of each concentration gradient of each target bacteria specimen, and selecting the lowest concentration with the positive detection rate of more than or equal to 95 percent as the LoD value of each target bacteria.
1.1.2 classical protocol
Using ultrapure water as a substrate, DNAs of different target bacteria at known concentrations were incorporated, respectively, to prepare positive specimens. Then, the samples were diluted with respective ultrapure water to five concentrations of 1 × LoB, 2 × LoB, 3 × LoB, 4 × LoB, and 5 × LoB, and used as low-value specimens.
The same set of instruments including a droplet generation instrument, a PCR amplification instrument and a chip reader are used, 3 batch number reagents are used, five low-value samples of each target bacterium are respectively and repeatedly detected for at least 12 times, and the total number of the measurement results of at least 60 low-value samples is measured.
Respectively calculating LoD values of the target bacteria, wherein the method comprises the following steps:
1) The data distribution of at least 60 low value specimen measurements per lot of reagent is analyzed.
2) If the data are normally distributed, a parameter statistical method is adopted for analysis.
3) If the data are distributed in a biased way, a nonparametric statistical method is adopted for analysis.
The limit of detection is the LoD value, and the results are shown in the following table:
TABLE 11
The results show that the sensitivity of the primer probe system (table 2) using mitochondrial genes as detection targets is obviously higher than that of the primer probe system using 28sRNA as detection targets.
The foregoing is only a preferred embodiment of the present invention, and it should be noted that it is obvious to those skilled in the art that various modifications and improvements can be made without departing from the principle of the present invention, and these modifications and improvements should also be considered as the protection scope of the present invention.
Claims (10)
1. A primer probe combination for detecting three lung invasive fungi, comprising:
primers and probes for detecting aspergillus: 1-2 and 3 respectively;
and (3) primers and probes for detecting cryptococcus neoformans: primers of the nucleotide sequences shown in SEQ ID NO. 4-5 and probes of the nucleotide sequences shown in SEQ ID NO. 6; and/or
Primers and probes for detecting yersinia sporogenes: primers of nucleotide sequences shown in SEQ ID NO. 7-8 and probes of nucleotide sequences shown in SEQ ID NO. 9.
2. The primer probe combination of claim 1, wherein the probe is labeled with a fluorescent group at the 5 'end and a quenching group at the 3' end;
the fluorescent group is selected from FAM, ROX, VIC, CY5, ATTO-425, HEX, TAMRA, CY5.5, CY7, ATTO-488, ATTO-550, ATTO-565, ATTO-590, ATTO-635, ATTO-532, ATTO-549 and ATTO-633; the quenching group is selected from MGB or BHQ1, BHQ2 and BHQ3.
3. The primer-probe combination according to claim 2,
the 5 'end of the probe of the nucleotide sequence shown in SEQ ID NO. 3 is marked with a fluorescence reporter group FAM, and the 3' end is marked with a fluorescence quenching group MGB;
the 5 'end of the probe of the nucleotide sequence shown in SEQ ID NO. 6 is marked with a fluorescence reporter group ROX, and the 3' end is marked with a fluorescence quenching group MGB;
the 5 'end of the probe of the nucleotide sequence shown in SEQ ID NO. 9 is marked with a fluorescence reporter group CY5, and the 3' end is marked with a fluorescence quenching group MGB.
4. Use of the primer probe combination of any one of claims 1 to 3 for the preparation of a kit for the diagnosis of pulmonary diseases.
5. The use of claim 4, wherein the pulmonary disease is a disease induced by infection with at least one pathogenic bacterium selected from the group consisting of Aspergillus fumigatus, cryptococcus neoformans and Pneumocystis yeri.
6. A kit for diagnosing a pulmonary disease, comprising the primer probe combination according to any one of claims 1 to 3.
7. The kit of claim 6, further comprising primers and probes for detecting an internal reference gene: the primer sequence is shown as SEQ ID NO 10-11; the probe sequence is shown in SEQ ID NO. 12.
8. The kit according to claim 7, wherein the probe represented by SEQ ID NO. 12 is labeled at the 5 'end with a fluorescence reporter group VIC and at the 3' end with a fluorescence quencher group BHQ1.
9. A method for the detection of pathogenic bacteria in the lung for non-diagnostic purposes, characterized in that a sample to be tested is subjected to digital PCR detection using the primer probe set according to any one of claims 1 to 3 or the kit according to any one of claims 6 to 8.
10. The method of claim 9, wherein the digital PCR detection procedure comprises: pre-denaturation at 98 ℃ for 5min; denaturation at 98 ℃ for 15 seconds, annealing at 60 ℃ for 30 seconds, and circulation for 40 times.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211632077.1A CN115820921B (en) | 2022-12-19 | 2022-12-19 | Primer probe combination for detecting three lung invasive fungi and digital PCR kit thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211632077.1A CN115820921B (en) | 2022-12-19 | 2022-12-19 | Primer probe combination for detecting three lung invasive fungi and digital PCR kit thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115820921A true CN115820921A (en) | 2023-03-21 |
CN115820921B CN115820921B (en) | 2024-07-05 |
Family
ID=85516615
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211632077.1A Active CN115820921B (en) | 2022-12-19 | 2022-12-19 | Primer probe combination for detecting three lung invasive fungi and digital PCR kit thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115820921B (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117051168A (en) * | 2023-10-11 | 2023-11-14 | 北京量觉科技有限责任公司 | Primer probe combination, method and kit for detecting cryptococcus |
CN117512204A (en) * | 2024-01-05 | 2024-02-06 | 江苏美克医学技术有限公司 | Primer and probe combination for multiplex detection of aspergillus, cryptococcus and yersinia, kit and application |
CN117568509A (en) * | 2023-11-17 | 2024-02-20 | 厦门飞朔生物技术有限公司 | Primer probe combination for detecting aspergillus, penicillium and fusarium based on microdroplet digital PCR technology and application |
CN117965800A (en) * | 2024-03-29 | 2024-05-03 | 南京诺因生物科技有限公司 | Compositions and kits for QPCR-based detection of Aspergillus fumigatus, yersinia pneumoconica and Cryptococcus neoformans |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107636172A (en) * | 2015-04-15 | 2018-01-26 | 巴斯德研究所 | For diagnosing, predicting or monitoring the instrument of pneumocystis pneumonia |
CN111607658A (en) * | 2020-05-29 | 2020-09-01 | 领航基因科技(杭州)有限公司 | Primer probe system, kit and detection method for human fungal infection detection |
CN115820922A (en) * | 2022-12-19 | 2023-03-21 | 领航基因科技(杭州)有限公司 | Primer probe combination and kit for detecting cryptococcus |
CN115961070A (en) * | 2022-09-15 | 2023-04-14 | 领航基因科技(杭州)有限公司 | Primer probe combination and kit for detecting aspergillus |
-
2022
- 2022-12-19 CN CN202211632077.1A patent/CN115820921B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107636172A (en) * | 2015-04-15 | 2018-01-26 | 巴斯德研究所 | For diagnosing, predicting or monitoring the instrument of pneumocystis pneumonia |
CN111607658A (en) * | 2020-05-29 | 2020-09-01 | 领航基因科技(杭州)有限公司 | Primer probe system, kit and detection method for human fungal infection detection |
CN115961070A (en) * | 2022-09-15 | 2023-04-14 | 领航基因科技(杭州)有限公司 | Primer probe combination and kit for detecting aspergillus |
CN115820922A (en) * | 2022-12-19 | 2023-03-21 | 领航基因科技(杭州)有限公司 | Primer probe combination and kit for detecting cryptococcus |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117051168A (en) * | 2023-10-11 | 2023-11-14 | 北京量觉科技有限责任公司 | Primer probe combination, method and kit for detecting cryptococcus |
CN117568509A (en) * | 2023-11-17 | 2024-02-20 | 厦门飞朔生物技术有限公司 | Primer probe combination for detecting aspergillus, penicillium and fusarium based on microdroplet digital PCR technology and application |
CN117512204A (en) * | 2024-01-05 | 2024-02-06 | 江苏美克医学技术有限公司 | Primer and probe combination for multiplex detection of aspergillus, cryptococcus and yersinia, kit and application |
CN117512204B (en) * | 2024-01-05 | 2024-04-09 | 江苏美克医学技术有限公司 | Primer and probe combination for multiplex detection of aspergillus, cryptococcus and yersinia, kit and application |
CN117965800A (en) * | 2024-03-29 | 2024-05-03 | 南京诺因生物科技有限公司 | Compositions and kits for QPCR-based detection of Aspergillus fumigatus, yersinia pneumoconica and Cryptococcus neoformans |
Also Published As
Publication number | Publication date |
---|---|
CN115820921B (en) | 2024-07-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN115820921B (en) | Primer probe combination for detecting three lung invasive fungi and digital PCR kit thereof | |
CN111500771B (en) | Primer group and kit for detecting novel coronavirus SARS-CoV-2 | |
CN111020062A (en) | Triple real-time fluorescent quantitative PCR kit for detecting African swine fever wild strain and gene deletion strain | |
CN108060263B (en) | Primer probe combination and fluorescent quantitative PCR kit for simultaneously detecting three cryptococci | |
CN115820922B (en) | Primer probe combination and kit for detecting cryptococcus | |
CN110904225A (en) | Combined marker for liver cancer detection and application thereof | |
CN108034745A (en) | Primer combination of probe and kit a kind of while that detect four kinds of candida albicans | |
CN113999933A (en) | Method for accurately detecting cryptococcus neoformans | |
CN111926116A (en) | Primer and probe for rapidly and quantitatively detecting duck adenovirus type 4, detection method and application thereof | |
CN108070675B (en) | Primer probe combination and fluorescent quantitative PCR kit for simultaneously detecting three kinds of aspergillus | |
CN113862393A (en) | Method for rapidly detecting cryptococcus gatherensis | |
CN108707691A (en) | A kind of primer combination of probe of specific detection aspergillus fumigatus and the kit that aspergillus fumigatus is detected based on fluorescent PCR method | |
CN111607658A (en) | Primer probe system, kit and detection method for human fungal infection detection | |
CN115961070A (en) | Primer probe combination and kit for detecting aspergillus | |
CN111454943A (en) | Novel coronavirus detection kit | |
CN113355460B (en) | Primer and kit for detecting novel goose reovirus, and detection method and application thereof | |
CN114908084B (en) | Primer probe of cercospora spinosa, aspergillus terreus and aspergillus nidulans and application thereof | |
CN111004868A (en) | Fluorescent PCR (polymerase chain reaction) primer, probe and kit for detecting goat intranasal tumor virus | |
CN114908085A (en) | Primer, probe and kit for PCR detection of rhizopus | |
CN113444842B (en) | Specific primer group for fox retrovirus detection and application of PCR detection kit | |
CN116445647A (en) | Kit for detecting aspergillus, rhizopus and mucor | |
CN109207623B (en) | Fluorescent PCR (polymerase chain reaction) primer, probe and detection kit for identifying three sporothrix bacteria | |
AU2021102364A4 (en) | Fluorescent pcr primer, probe and kit for detecting bovine rhinitis b virus | |
CN114807432B (en) | Kit and method for rapidly detecting novel coronavirus and Delta mutant strain thereof | |
CN115961057B (en) | Echinococcosis detection primer, probe, kit and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant |